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Pathways that regulate epigenetic control of stem cell identity are critical to the molecular etiology of cancer.
In back-to-back articles in Cell and Cell Stem Cell, Song et al. identify miR-22 as both a repressor of TET pro-
teins and a powerful oncogene in the mammary epithelium and hematopoietic system.One of the fundamental traits of malignant
tumors is their capacity to grow indefi-
nitely, beyond the natural limits usually
observed for most normal, differentiated
cells. This property, often referred to as
immortality, was among the very first to
be recognized by cellular oncologists
and is regarded as a fundamental hall-
mark of the transformed phenotype
(Hanahan and Weinberg, 2011). In the
eye of the stem cell biologist, however,
the capacity for extensive growth and
expansion does not constitute, in and of
itself, a pathological trait. By definition,
stem cells are selectively endowed with
the capacity to self-renew: they preserve
intact their ability for long-term expansion
over multiple rounds of sequential
divisions, and serve as a constant source
of mature cells throughout the lifetime of
an organism. If considered from this
perspective, therefore, immortality could
be interpreted as a pathological form of
self-renewal, in which the normal con-
straints that regulate stem cell expansion
and ensure homeostatic control of tissue
size have been disabled as the result of
oncogenic mutations (Dalerba et al.,
2007). Our ability to test this concept has
been limited by an incomplete under-
standing of the basic molecular circuitry
that defines the epigenetic identity of
normal stem cells and the degree to which
this circuitry is either mirrored or hijacked
by cancer cells.
In an impressive tour de force that
combines evidence from two indepen-
dent studies (Song et al., 2013a, 2013b),
Song and colleagues have now identified
miR-22 to be both a new regulator of the
self-renewal machinery and a powerful
oncogene that directly targets multiple
members of the ‘‘ten-eleven-transloca-
tion’’ (TET) protein family, a group ofenzymes involved in DNA demethylation.
In their first study (Song et al., 2013b),
the authors examined the effects of
constitutive miR-22 overexpression on
the breast epithelium using transgenic
mice engineered to achieve constitutive
expression of miR-22 inmammary epithe-
lial cells. Their results indicate that miR-22
overexpression causes epithelial cells
to acquire biochemical features of
the epithelial-to-mesenchymal transition
(EMT), such as downregulation of E-cad-
herin and upregulation of Zeb1. In addi-
tion, miR-22 overexpression is associated
with upregulation of the Bmi1 oncogene
and an increase in the frequency of
normal mammary stem/progenitor cells,
which can reconstitute full mammary
epithelial trees in transplantation assays.
These changes are followed by sponta-
neous neoplastic transformation of
normal mouse breast epithelia into meta-
static breast carcinomas. When com-
bined with additional oncogenic insults,
such as when miR-22 transgenic mice
are crossed with MMTV-PyVT or MMTV-
neu transgenic mice, constitutive miR-22
overexpression accelerates both tumor
progression and metastasis. Finally, high
levels of miR-22 expression are associ-
ated with high-grade tumors and reduced
survival in breast cancer patients.
In their second study (Song et al.,
2013a), the authors used a similar trans-
genic approach to investigate the effects
of constitutive miR-22 overexpression on
mouse hematopoietic cells. In this second
case, however, miR-22 overexpression
was not specific to the hematopoietic
system and the authors decided to test
the effects of increased miR-22 dosage
using transplantation assays. Constitutive
miR-22 overexpression augmented the
proliferative capacity of hematopoieticCell Stemstem/progenitor cells (HSPCs), causing
them to progressively outcompete their
wild-type counterparts in cotransplanta-
tion experiments. When observed for
longer periods of time, transplanted
HSPCs overexpressing miR-22 gave rise
to a disease reminiscent of a myelodis-
plastic syndrome (MDS), which subse-
quently progressed to full-blown acute
myeloid leukemia (AML). As observed in
the case of breast cancer, high levels of
miR-22 expression were associated with
reduced survival in human MDS patients.
In both the mammary epithelium and
the hematopoietic system, the biological
effects of miR-22 were mediated by its
capacity to suppress expression of TET
family members. TET proteins are DNA
hydroxylases that convert 5-methylcyto-
sine into 5-hydroxymethylcytosine to
initiate DNA demethylation (Wu and
Zhang, 2011). Indeed, genetic inactivation
of TET proteins is known to disrupt
the epigenetic remodeling that accom-
panies normal differentiation processes,
and TET mutations are commonly
observed in human hematological malig-
nancies. Similar to constitutive miR-22
overexpression, genetic inactivation of
Tet2 in mice is associated with a numeri-
cal expansion of HSPCs and neoplastic
transformation (Cimmino et al., 2011).
In a fascinating set of experiments,
Song and collaborators also showed
that constitutive miR-22 overexpression
is associated with hypermethylation and
epigenetic silencing of the miR-200c
promoter. This is accompanied by upre-
gulation of Bmi1, a key member of the
Polycomb group (PcG) protein family
and a core element of the self-renewal
machinery in both hematopoietic and
mammary epithelial stem cells (Park
et al., 2003; Pietersen et al., 2008). TheseCell 13, July 3, 2013 ª2013 Elsevier Inc. 5
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ports that identified human miR-200c as
a direct repressor of BMI1, limiting the
expansion and tumorigenicity of breast
cancer cells (Shimono et al., 2009). Impor-
tantly, the effects of miR-22 on the
expression of miR-200c and Bmi1 are
mediated through a direct interaction of
miR-22 with TET mRNAs and can be
reproduced in a line of immortalized
mammary epithelial cells by shRNA-
mediated knockdown of TET2 and TET3.
These observations provide fundamental
mechanistic insights into developmental
biology in that they explain how different
arms of the molecular machinery that
shapes the epigenetic identity of stem
cells work together in an integrated sys-
tem to control the capacity to self-renew.
Members of the TET family act as initia-
tors of DNA demethylation while Bmi1, a
member of the Polycomb repressor
complex 1 (PRC1), regulates chromatin
remodeling through specific histonemod-
ifications such as ubiquitination of lysine-
119 of histone-2A. Both systems oversee
the coordinated regulation of multiple
gene expression programs during differ-
entiation. Learning how these epigenetic
pathways interact is a fundamental step
toward understanding how even relatively
subtle genetic manipulations (e.g. the
constitutive expression of one miRNA)
can ‘‘ripple’’ into profound perturbations6 Cell Stem Cell 13, July 3, 2013 ª2013 Elsevof stem cell homeostasis and cause
cancer.
In our opinion, however, the most
compelling finding that emerges from
the aggregate work of Song and collab-
orators is that chromatin-remodeling
systems with opposing effects on cell
identity (self-renewal versus differentia-
tion) appear to directly antagonize each
other through opposing sets of miRNAs
(e.g. miR-22 versus miR-200c). A series
of theoretical questions thus arises. If
chromatin-remodeling systems directly
antagonize each other as part of a dy-
namic equilibrium between self-renewal
and differentiation, what tilts the balance
toward one fate or the other? Under phys-
iological conditions, what makes changes
in stem cell identity (i.e., differentiation)
irreversible? The answer to these ques-
tions lies in a more advanced, systems-
level understanding of these molecular
circuitries and in a deeper characteriza-
tion of their positive and negative feed-
back loops. For example, are members
of the Polycomb family able to regulate
miR-22 expression? If so, do they posi-
tively affect miR-22 expression, thus
‘‘locking’’ the stem cell identity in a self-
reinforcing loop, or do they suppress it,
thus ‘‘limiting’’ the stem cell identity in a
cell-autonomous manner? The challenge
for the future will be to develop new
experimental approaches, and mathe-ier Inc.matical algorithms, to model the inte-
grated action of these complex relation-
ships and their impact on cell fate
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Fluctuating expression of transcription factors in embryonic stem cells is an alluring observation, but, as
outlined by two articles in this issue, appearances can be misleading.Mouse embryonic stem cells (ESCs)
closely approximate pluripotent embryo
founder cells resident in the blastocyst.
However, it is important to keep in mind
that ESC propagation is a cell culture phe-
nomenon. ESCs may be liberated from
constraints imposed by the develop-mental program in vivo, but they are also
subject to stimuli and conditions that do
not occur in the embryo. Depending on
the specific culture setting, ESCs exhibit
different morphology, gene expression,
epigenetic features, and self-renewal effi-
ciency (Wray et al., 2010). Notably, ESCson a feeder layer present as homogenous
clusters of small, tightly packed cells,
whereas without feeders and in the pres-
ence of leukemia inhibitory factor (LIF),
ESCs are flattened and exhibit heteroge-
neous morphologies. A suite of transcrip-
tion factors is expressed in a mosaic
